---
figid: PMC4120774__nihms-314392-f0006
figlink: /pmc/articles/PMC4120774/figure/F6/
number: Figure - 6
caption: Multiple growth factor receptors are activated at the cell surface during
  cancer. Activation of these receptors activates several downstream signaling pathways.
  Among these pathways the Ras-MAPK, the P13K-Akt, mTOR and NF-κB pathways are of
  significance and targets of DIM. By dephosphorylating these molecules, DIM modulates
  downstream signaling pathways impinging on proliferation, angiogenesis and apoptosis.
  NF-kB pathway is inactive as a result of the binding of p50 and p65 to IκB. When
  IκB is phosphorylated by IKKs and degraded, p50 and p65 are set free and are translocated
  into the nucleus to activate a specific set of genes. This pathway has been shown
  to be inhibited both in vitro and in vivo by DIM. Activation of AP-1 is primarily
  mediated by MAPK, especially through the phosphorylation by c-Jun N-terminal kinase
  (JNK), which leads to translocation of AP-1 and subsequent transcriptional activation
  of target genes
pmcid: PMC4120774
papertitle: 'ATTENUATION OF MULTI-TARGETED PROLIFERATION-LINKED SIGNALING BY 3,3′-DIINDOLYLMETHANE
  (DIM): FROM BENCH TO CLINIC.'
reftext: Sanjeev Banerjee, et al. Mutat Res. ;728(0):47-66.
pmc_ranked_result_index: '14400'
pathway_score: 0.9323024
filename: nihms-314392-f0006.jpg
figtitle: 'ATTENUATION OF MULTI-TARGETED PROLIFERATION-LINKED SIGNALING BY 3,3′-DIINDOLYLMETHANE
  (DIM): FROM BENCH TO CLINIC'
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4120774__nihms-314392-f0006.html
  '@type': Dataset
  description: Multiple growth factor receptors are activated at the cell surface
    during cancer. Activation of these receptors activates several downstream signaling
    pathways. Among these pathways the Ras-MAPK, the P13K-Akt, mTOR and NF-κB pathways
    are of significance and targets of DIM. By dephosphorylating these molecules,
    DIM modulates downstream signaling pathways impinging on proliferation, angiogenesis
    and apoptosis. NF-kB pathway is inactive as a result of the binding of p50 and
    p65 to IκB. When IκB is phosphorylated by IKKs and degraded, p50 and p65 are set
    free and are translocated into the nucleus to activate a specific set of genes.
    This pathway has been shown to be inhibited both in vitro and in vivo by DIM.
    Activation of AP-1 is primarily mediated by MAPK, especially through the phosphorylation
    by c-Jun N-terminal kinase (JNK), which leads to translocation of AP-1 and subsequent
    transcriptional activation of target genes
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - RAF1
  - PIK3R5
  - KRAS
  - PIK3R4
  - AKT2
  - PIK3R6
  - NFKBIA
  - SOS2
  - FOSL1
  - PDK1
  - MTOR
  - AKT1
  - HRAS
  - PIK3CA
  - PIK3CB
  - MLST8
  - FOSL2
  - PIK3CD
  - MAP2K2
  - AKT3
  - ARAF
  - NRAS
  - FOS
  - FOSB
  - RPTOR
  - MAPK3
  - PIK3CG
  - PIK3R3
  - MAPK1
  - SHC1
  - JUN
  - BRAF
  - SHC2
  - JUND
  - JUNB
  - SHC3
  - SHC4
  - SOS1
  - Ser
  - Thr
  - Tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IkBa
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: (AP1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: (PDK1/2
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: GBL
  symbol: GbetaL
  source: hgnc_alias_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: (AP1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: (AP1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: (AP1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: Raptor
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: (AP1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: (AP1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: (AP1)
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
chemicals:
- word: Ser
  source: MESH
  identifier: D012694
- word: Thr
  source: MESH
  identifier: D013912
- word: Tyrosine
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
